Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05158153 · ClinicalTrials.gov registry record · Phase 4
Outpatient Recovery From Acute Kidney Injury Requiring Dialysis
A Phase 4 study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1
- Enrollment target
NCT05158153 is a Phase 4 study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 1 participants.
The verdict
NCT05158153, a Phase 4 study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1 participants
- Enrollment target
Study Summary
There are currently no therapies to improve the chances of recovering enough kidney function to come off of dialysis after severe acute kidney injury. It is not known if current routine outpatient dialysis treatments are optimized to maximize the chances of recovery. The purpose of this pilot study is to see if we can feasibly and safely provide several changes to the way that dialysis is provided in outpatient dialysis centers which may improve the chances of recovery.
Interventions
- DRUG Furosemide
- OTHER ORKID Bundled Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-10-18 |
| Est. Completion | 2022-04-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05158153
The ClinicalTrials.gov registry entry for NCT05158153 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Furosemide is the first listed.
NCT05158153 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05158153 about?
NCT05158153 is a clinical study titled "Outpatient Recovery From Acute Kidney Injury Requiring Dialysis". There are currently no therapies to improve the chances of recovering enough kidney function to come off of dialysis after severe acute kidney injury. It is not known if current routine outpatient dialysis treatments are optimized to maximize the chances of recovery. The purpose of this pilot study ...
What is the current status of trial NCT05158153?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1 participants. The study started on 2021-10-18. Estimated completion is 2022-04-19.
What interventions are being tested in trial NCT05158153?
The interventions under investigation include: Furosemide (DRUG), ORKID Bundled Intervention (OTHER).
Who is sponsoring clinical trial NCT05158153?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.